The pledge was signed by the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi.
The drugmakers promised to prioritize vaccine safety, conduct clinical trials scientifically and ethically, pursue a range of vaccine offerings and only submit treatments for FDA approval after they have maintained safety and efficacy through phase 3 testing.
“We believe this pledge will help ensure public confidence in the rigorous scientific and regulatory process by which COVID-19 vaccines are evaluated and may ultimately be approved,” the drugmakers wrote.
Read the full pledge here.
More articles on pharmacy:
5 requests biotech CEOs have for their peers, the FDA regarding COVID-19 vaccine development
CDC sends plans to states for COVID-19 vaccine distribution by early November
Operation Warp Speed head: ‘I would immediately resign if there is undue interference’
